Fentanyl Injectable Solution Recalled for Unvalidated Sterilization Cycles
Central Admixture Pharmacy Services is recalling 848 bags of fentanyl injection nationwide due to lack of validated sterilization processes that assure product sterility. Multiple lots distributed to healthcare facilities are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification with a risk-of-harm product (injectable pharmaceutical) due to unvalidated sterilization processes creating potential contamination risk. No illnesses, injuries, or deaths are reported in the source, so per the rubric this meets the criteria for High (3) rather than Severe (4).
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 848 bags of fentanyl injection (2500 mcg/50 mL, 50 mcg/mL, in 100 mL bags). The product was distributed nationwide.
The recall was initiated because validation data for sanitization cycles was not available, meaning the company cannot assure that the sterilization process was effective. This creates a potential risk that the distributed product may not be sterile and could be contaminated.
Affected lots include: 17-270533 (Exp. 7/16/2023), 17-270580 and 17-270581 (Exp. 7/17/2023), 17-270654 (Exp. 7/18/2023), 17-271044 (Exp. 7/24/2023), 17-271243 (Exp. 7/26/2023), 17-271439 (Exp. 7/30/2023), and 17-271562 (Exp. 8/1/2023). Healthcare facilities and pharmacies that received these lots should verify their inventory.
If your facility has received this product, do not use it. Contact Central Admixture Pharmacy Services, Inc. at 7935 Dunbrook Road, Suite C, San Diego, CA 92126, or notify the FDA for return instructions.
The recalled product
- Product
- fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-4
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Compounded Injectable
- Affected units
- 848
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot: 17-270533
- Exp. 7/16/2023
- 17-270580
- 17-270581
- Exp. 7/17/2023
- 17-270654
- Exp. 7/18/2023
- 17-271044
- Exp. 7/24/2023
- 17-271243
- Exp. 7/26/2023
- 17-271439
- Exp. 7/30/2023
- 17-271562
- Exp. 8/1/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Central Admixture Pharmacy Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services Inc
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22